Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 10,858

Document Document Title
WO/2015/159272A3
Curcumin compositions herein are described for improving muscle performance, endurance capacity and resistance to fatigue, when administered in effective amounts to a subject in need of such improvement. The compositions are comprised of...  
WO/2015/161200A1
A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture a...  
WO/2015/158031A1
A DNA molecule comprising a sequence represented by SEQ ID NO:1, a pichia pastoris recombinant plasmid into which the DNA molecule is inserted, and a pichia pastoris recombinant bacterium for converting the pichia pastoris recombinant pl...  
WO/2015/154897A1
The present invention provides means and methods for treating disorders of copper metabolism in the brain of a subject comprising administering a therapeutically effective amount of chelators of copper encapsulated into liposomes which a...  
WO/2015/151001A1
The present invention relates to the compound of Formula (I) wherein the substituents are as described herein, and their use in a medicine for the treatment of diseases, disorders associated with the inhibition of Voltage-gated sodium ch...  
WO/2015/150824A1
The invention relates to compounds in the treatment or prevention of disorders associated with Lamin A and/or Lamin C depletion or LMNA mutations, such as laminopathy, premature ageing disorders, normal ageing and cancer(such as a cancer...  
WO/2015/149168A1
A process for producing a distilled ethanol product comprising an antioxidant component and an ethanol component is described. In the process, plant matter containing antioxidants is washed, frozen and exposed to an input volume of ethan...  
WO/2015/148522A1
This invention is about the compositions and methods for assessing and treating vascular endothelial dysfunction. Various aspects provide a method for treatment of vascular endothelial dysfunction, comprising administering a composition ...  
WO/2015/142218A1
The invention relates to medicine, particularly to neurology and cardiology, and also to surgery and traumatology, and specifically relates to medicinal agents exhibiting cytoprotective activity in the presence of ischemia-reperfusion...  
WO/2015/142924A1
Multivalent cation compositions of partially desulfated heparins are presented. Multivalent cation compositions of the disclosure can be formulated at high concentrations. The compositions, processes for making the compositions, unit dos...  
WO/2015/137499A3
 A hydrogen molecule-supplying exterior body (1) for producing a hydrogen-containing biological application solution, said hydrogen molecule-supplying exterior body (1) being provided with a water vapor-permeable container (12) in whic...  
WO/2015/137499A2
 A hydrogen molecule-supplying exterior body (1) for producing a hydrogen-containing biological application solution, said hydrogen molecule-supplying exterior body (1) being provided with a water vapor-permeable container (12) in whic...  
WO/2015/133716A1
The present invention relates to a pharmaceutical composition for the prevention and treatment of cell or tissue damage caused by radiation comprising hesperetin or the pharmaceutically acceptable salts thereof as an active ingredient. P...  
WO/2015/127714A1
Provided is an application of baicalin in preparation of a drug for treating ricin poisoning. A Hela cytoprotection test and a mouse ricin poisoning model have verified the recovery effect of baicalin on ricin poisoning.  
WO/2015/124581A1
The present invention relates to reverse-micellar systems comprising at least an active agent, an acylglycerol, a sterol, lecithin, ethanol and water, for use in chelation and/or sequestering of a radionuclide and/or a metal in a patient...  
WO/2015/118488A1
The invention relates to an agent for treating cardiovascular diseases consisting of a mixture of two structural isomers of 4-methyl-2,6-di-isobornyl phenol with an isomer ratio of from 60:40%wt. to 95:5%wt.  
WO/2015/109935A1
The invention generally relates to compounds of formula (I) with neural protective effect, and preparation and uses thereof. The compounds have multiple mechanisms or functions, for example, inhibition of monoamine oxidase and cholineste...  
WO/2015/109666A1
Disclosed are an ester group-containing aromatic propionamide compound, and a preparation method therefor and uses thereof, and provides a chemical structure formula of the new ester group-containing aromatic propionamide compound. The c...  
WO/2015/106678A1
Uses of progesterone in the preparation of drugs for treatment or prevention of altitude sickness caused by hypobaric hypoxia. The progesterone has preventive and treatment effects on acute high altitude disease or high altitude cerebral...  
WO/2015/096725A1
Provided are a linear lipopeptide with an end group having a lipophilic structure, a preparation method for the lipopeptide, and a use thereof in preparing an anti-radiation injury medicament. The lipopeptide is one lipophilic structural...  
WO/2015/092763A1
The present invention in one aspect relates to a nutritional composition for the prevention and/or treatment of COPD and symptoms related to it, comprising N- acetylcysteine and/or a physiologically acceptable salt thereof in association...  
WO/2015/095553A1
The present disclosure relates to a dialysis apparatus comprising a membrane having at least one protein from the lipocalin family bound thereon. The disclosure further relates to methods of removing non-polar, hydrophobic and/or protein...  
WO/2015/088233A1
Disclosed are an antioxidative peptide having a sequence of any one of SEQ ID NOs: 1 to 340, a peptide which is a fragment of sequences of SEQ ID NOs: 1 to 340, or a peptide having at least 80% sequence identity with the peptide sequence...  
WO/2015/083554A1
The problem addressed by the present invention is to provide a 4G-α-glucosylrutin crystal, a 4G-α-glucosylrutin crystal-containing powder, an application of same as a drug starting material, and applications as a cosmetic product start...  
WO/2015/076294A1
[Problem] To suppress the onset of adverse effects of drugs that cause gastric ulcers as an adverse effect. [Solution] The onset of gastric ulcers induced by a drug is suppressed by incorporating, into a pharmaceutical composition contai...  
WO/2015/076667A1
The present invention relates to a composition for managing menopause in a human or animal body, characterized in that said composition comprises a germinated brown rice derived compound.  
WO/2015/074115A1
The invention described in this specification relates to the prevention and treatment of alkaloid-induced toxicosis in pasture grazing animals.  
WO/2015/070280A1
The present invention relates to a method of treating or preventing DNA damage in a cell or cellular senescence of a cell or induction of the senescence associated secretory phenotype (SASP) in a cell, or for treating or preventing the e...  
WO/2015/069974A1
Capsules containing nutritional supplement formulations are disclosed which include a lipophilic MDG carrier oil comprising a mixture of monoglycerides and diglycerides, but with no more than 10% triglycerides. One or more lipophilic nut...  
WO/2015/066190A1
The present invention is directed to methods for the treatment or prevention of oxidative stress in a cell, e.g., photoreceptor cell, and methods for the treatment and prevention of disorders associated therewith by the administration of...  
WO/2015/065937A1
Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and compounds I for use to treat or prevent diseases or conditions associated with the ...  
WO/2015/064764A1
Provided is an aryloyl(oxy or amino)pentafluorosulfanylbenzene compound having pharmacological action. The present invention relates to an aryloyl(oxy or amino)pentafluorosulfanylbenzene compound represented by general formula (A-I), a p...  
WO/2015/058034A1
The present invention provides methods for reducing apoptosis of non-cancerous cells during a cancer treatment and beneficial effects associated with reducing such apoptosis. In particular, methods of the invention comprise administering...  
WO/2015/057726A1
A composition comprising an effective amount of a combination of mitochondrial nutrients sufficient to affect mitochondrial function. A method of affecting an aging process in a subject comprising administering to a subject an effective ...  
WO/2015/053336A1
Provided are: an anti-fatigue composition resulting from the combined use of (1) histidine and (2) vitamin B6 and/or carnosine; and a food or the like containing (1) histidine and (2) vitamin B6 and/or carnosine in the form of being pack...  
WO/2015/044180A1
The invention concerns a substance for reducing tissue calcification and tissue fibrosation, delaying the onset of age-related diseases of a living being, and associated methods.  
WO/2015/042821A1
Disclosed are a compound for activating AMPK, which is an adenine and/or a pharmaceutically acceptable salt, and disclosed is a use of the compound for preventing or treating physiological conditions or diseases in mammals which can be a...  
WO/2015/047647A1
Ionic liquid compositions derived from imidazolium based ionic liquids that have been thermally treated or thermally and oxidatively treated are disclosed. These compositions can be utilized as the medium for oxidation of alkylaromatic c...  
WO/2015/046365A1
 The purpose of the present invention is to provide an emulsifiable formulation of a liposoluble substance that improves the emulsifiability of the liposoluble substance. The water dispersibility of a liposoluble carotenoid can be impr...  
WO/2015/028850A1
Provided are cytotoxic agents, pyrrolo[2,1-c][1,4]benzodiazepine (PBD) derivatives, their conjugates with a cell-binding agent, the preparation and the therapeutic uses in the targeted treatment of cancers, autoimmune disorders, and infe...  
WO/2015/028027A1
The present disclosure concerns monoclonal antibodies directed to the pro-domain of ADAM 12 and their use in the treatment of cancer.  
WO/2015/030106A1
The present invention relates to compounds represented by general formula (I) (where Z, R, Ra, R', * and n are each as defined in the description) or salts thereof.  
WO/2015/027565A1
An L-carnitine micro-capsule powder and preparation method thereof, the L-carnitine micro-capsule powder comprising: L-carnitine, maltodextrin, arabic gum, gelatin, and sodium ascorbate; the preparation method comprises the following ste...  
WO/2015/028286A1
A polymer of formula (I) where X1 and X2 respectively represent the alpha and omega end groups of the polymer; R1 represents a hydrogen atom or a straight or branched chain alkyl group; R2 represents a straight or branched chain alkyl gr...  
WO/2015/024100A1
A method of providing anesthesia and organ-protection to a subject in need thereof comprises co-administering to the subject a non-anesthetic protective gas in an amount effect to provide organ protection, and a liquid anesthetic agent i...  
WO/2015/025528A1
The present invention addresses the problem of providing a novel free radical scavenger which can solve problems occurring in existing free radical production inhibitors/scavengers, such as the induction of inflammation. Specifically, th...  
WO/2015/020138A1
 The purpose of the present invention is to provide a means for promoting the in vivo absorption of hydroxytyrosol or a derivative thereof, prolonging the in vivo residence time, and sustaining the effect. As a result of in-depth studi...  
WO/2015/015989A1
The purpose of the present invention is to provide an agent for alleviating side effects in cancer chemotherapy, said agent being capable of alleviating various side effects in cancer chemotherapy and thus increasing the treatment comple...  
WO/2015/014209A1
Provided in the present invention is a method for detoxification in healthy human beings and lung disease patients using pyruvate pharmaceutical compositions. Toxins accumulated in mammalian cells because of smoking and air pollution can...  
WO/2015/010498A1
A natural herb composition for rapidly cleaning body metabolic toxins is prepared by using the following raw materials in part by mass, the raw materials comprise a mangosteen extract, an aloe extract, and a hot-water extract of a mixtur...  

Matches 101 - 150 out of 10,858